Impacts of the COVID-19 pandemic on pediatric and adult patients with hemophilia

2024-9-14

Correction to: Comorbidities and survival of multiple myeloma patients diagnosed in Finland between 2000 and 2021

2024-9-14

The effects of complement-independent, autoantibody-induced apoptosis of platelets in immune thrombocytopenia (ITP)

2024-9-14

Acalabrutinib in Chinese patients with relapsed/refractory chronic lymphocytic leukemia: Primary analysis from an open-label, multicenter phase 1/2 trial

2024-9-14

Treatment-related leukoencephalopathy in adults with central nervous system lymphoma: a retrospective analysis of 126 patients

2024-9-13

Outcomes of chronic myeloid leukemia patients after therapeutic failure to conventional tyrosine kinase inhibitors and asciminib

2024-9-13

Treatment patterns and burden of infection in patients with chronic lymphocytic leukemia and secondary immunodeficiency: a retrospective database study

2024-9-12

Long-term complete remission in a patient with high-risk primary mediastinal B-cell lymphoma and iatrogenic symptomatic bradycardia after only two courses of DA-EPOCH-R followed by chemo-free treatment

2024-9-12

Licochalcone A decreases cancer cell proliferation and enhances ferroptosis in acute myeloid leukemia through suppressing the IGF2BP3/MDM2 cascade

2024-9-12

The role of long noncoding RNAs in the diagnosis, prognosis and therapeutic biomarkers of acute myeloid leukemia

2024-9-12

Flow cytometric expression of Bcl-2, Mcl-1, and their ratios correlates with primary and secondary cytogenetic changes and their combinations in multiple myeloma

2024-9-12

Initial US tertiary health care system experience using caplacizumab in patients with immune thrombotic thrombocytopenic purpura

2024-9-11

Analysis of Wilms’ tumor protein 1 specific TCR repertoire in AML patients uncovers higher diversity in patients in remission than in relapsed

2024-9-11

Baseline platelet count and long-term clinical outcomes in patients with acute venous thromboembolism: a prospective cohort study

2024-9-9

Safety of Rituximab biosimilar (Riximyo®) following a single switch from the reference product in patients with Non-Hodgkin’s lymphoma: a retrospective study

2024-9-9

Therapy-related myeloid neoplasms: a real-world pharmacovigilance analysis (1970–2023)

2024-9-9

Addition of ruxolitinib and decitabine to modified busulfan/cyclophosphamide conditioning regimen for prophylaxis relapse in high-risk acute myeloid leukemia: the phase 2 prospective study

2024-9-7

Outcomes by best response with hypomethylating agent plus venetoclax in adults with previously untreated acute myeloid leukemia

2024-9-7

Interventional antibiotic treatment replacing antibiotic prophylaxis during allogeneic hematopoietic stem cell transplantation is safe and leads to a reduction of antibiotic administration

2024-9-6

Allogeneic amnion transplantation for the management of cutaneous graft-versus-host disease with associated ulcers: A promising therapeutic strategy

2024-9-6

Antileukaemic rescue by dose-dense donor-lymphocyte infusions in T-PLL after allogeneic stem cell transplantation – a case report

2024-9-6

The effect of hetrombopag combined with conventional treatment on immune function and quality of life in patients with severe aplastic anemia

2024-9-5

Clinical characteristics and management of paroxysmal nocturnal haemoglobinuria in Latin America: a narrative review

2024-9-5

Prognostic value of hyperlactatemia and lactate clearance in septic patients with hematological malignancies

2024-9-5

An inherited genetic variant of the CEP72 gene is associated with the development of vincristine-induced peripheral neuropathy in female patients with aggressive B-cell lymphoma

2024-9-4

Aspergillus calidoustus and Talaromyces columbinus infections in chronic graft-versus-host disease

2024-9-4

Impact of clinically unsuspected venous thrombotic events on CVC removal and survival in pediatric cancer patients: A population-based study from the Maritimes, Canada

2024-9-4

A phase Ib trial of isatuximab, bendamustine, and prednisone in relapsed/refractory multiple myeloma

2024-9-4

Daratumumab, bortezomib, melphalan, and prednisone versus bortezomib, melphalan, and prednisone alone in transplant-ineligible Asian patients with newly diagnosed multiple myeloma: final analysis of the phase 3 OCTANS Study

2024-9-4

Early prediction of platelet recovery with immature platelet fraction in patients receiving hematopoietic stem cell transplantation

2024-9-3

Molecular insights into the hedgehog signaling pathway correlated non-coding RNAs in acute lymphoblastic leukemia, a bioinformatics study

2024-9-3

Early autologous and/or allogeneic stem cell transplantation for adult patients with advanced stage T- lymphoblastic leukemia/lymphoma or Burkitt lymphoma. A retrospective single-centre analysis

2024-9-3

Metabolic tumor volume from baseline [18 F]FDG PET/CT at diagnosis improves the IPI stratification in patients with diffuse large B-cell lymphoma

2024-9-2

The life threat in hematopoietic allogeneic stem cell transplantation - an interview and focus group study on health care professionals’ perspectives

2024-8-31

Investigation of infections status in pediatric patients with acute myeloid leukemia during the induction period–a retrospective study in two medical centers

2024-8-31

Cold case: COVID-19-triggered type 1 cryoglobulinemia

2024-8-31

Lymphocyte recovery after bendamustine therapy in patients with mantle cell lymphoma. Results of a retrospective analysis and prognostic impact in the CAR-T era

2024-8-30

Clinical management of patients diagnosed with acute myeloid leukemia treated with venetoclax in combination with hypomethylating agents after achieving a response: a real-life study

2024-8-29

Recent advances in acute gastrointestinal graft versus host disease (aGvHD): aspects of steroid-resistant disease

2024-8-29

Unravelling a KMT2A::ARHGEF12 fusion within chromoanagenesis in acute myeloid leukemia using Optical Genome Mapping

2024-8-29

Recent advancements in biomarkers, therapeutics, and associated challenges in acute myeloid leukemia

2024-8-29

Virus-driven dysregulation of the BCR pathway: a potential mechanism for the high prevalence of HIV related B-cell lymphoma

2024-8-28

Clonal heterogeneity in STAG2m myeloid neoplasms: the Mayo Clinic experience

2024-8-28

Light chain deposition disease: pathogenesis, clinical characteristics and treatment strategies

2024-8-28

MTHFR polymorphisms and vitamin B12 deficiency: correlation between mthfr polymorphisms and clinical and laboratory findings

2024-8-28

Predictive value of pre-treatment T lymphocyte subsets in patients with extranodal natural killer/T-cell lymphoma

2024-8-28

Non-syndromic congenital sideroblastic anaemia; phenotype, and genotype of 15 Indian patients

2024-8-28

Recent advances in CD5+ diffuse large B-cell lymphoma

2024-8-28

Circulating monocytes decrease significantly following disease-directed therapy and may reflect disease expansion in Langerhans Cell Histiocytosis

2024-8-27

Carfilzomib-induced thrombotic microangiopathy (TMA) refractory to eculizumab: A case report and literature review

2024-8-27